Advertisement

Topics

ImmuPharma sees "significant opportunity" for lupus drug after phase III trial readout

03:31 EDT 17 Apr 2018 | Proactive Investors

The company revealed there had been "expressions of interest" in its lupus programme which it will explore

Original Article: ImmuPharma sees "significant opportunity" for lupus drug after phase III trial readout

NEXT ARTICLE

More From BioPortfolio on "ImmuPharma sees "significant opportunity" for lupus drug after phase III trial readout"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Lupus
Lupus is a complex and poorly understood condition that affects many parts of the body and causes symptoms ranging from mild to life-threatening. There are several types of lupus. The main types are: discoid lupus erythematosus drug-induced lu...